Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma

Nano materials generate great benefits as well as new potential risks. Animal studies and in vitro experiments show that nanoparticles can result in lung damage and other toxicity, but no reports on the clinical toxicity in humans due to nanoparticles have yet been made.

The present study aimed to examine the relationship between a group of workers' presenting with mysterious symptomatic findings and their nanoparticle exposure.

http://erj.ersjournals.com/cgi/content/abstract/34/3/559?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=nano&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT

Envoyé: 2009-09-28 8:37 par Maryse Gagnon | avec 2 commentaire(s)

Classé sous : Agents chimiques, Nanotechnologies, Effets sur la santé

Commentaire

Maryse Gagnon a dit :

Environment Canada is developing and will soon publish a Notice in the Canada Gazette under the Canadian Environmental Protection Act requesting targeted companies or institutions to provide information on nanomaterials and nanotechnology. The information gathered will be used towards "the development of a regulatory framework" making Canada the first jurisdiction to require mandatory reporting of nanomaterials in the workplace.

Source : www.whsc.on.ca/whatnews2.cfm

# novembre 16, 2009 11:32

Maryse Gagnon a dit :

Nanoparticle exposure and occupational lung disease – six expert perspectives on a new clinical study

community.safenano.org/.../nanoparticle-exposure-and-occupational-lung-disease-six-expert-perspectives-on-a-new-clinical-study.aspx